trial

Implementation of National Guidelines for Treatment of Psychoses

NCTId NCT03271242
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 325 (actual)
Sponsored by University Hospital, Akershus
Primary completion 2018-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
325 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2016-06-22
Primary completion
2018-12-31
Eligibility
ALL · 16 Years

Interventions & indications

Drugs
Systematic implementation supportNo implementation support

Sponsors

University Hospital, AkershusLead Sponsor
University Hospital of North NorwayCollaborator
Helse Fonna Hospital TrustCollaborator
Helse Stavanger HFCollaborator
Sorlandet Hospital HFCollaborator
Sykehuset Innlandet HFCollaborator
WestatCollaborator
Mental helseCollaborator

Investigators

1
Torleif Ruud, MD, PhDPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
325
Phase
NA
Primary Completion Date
2018-12-31
Status
COMPLETED
relationships
The graph out of here
drug
Systematic implementation support
drug
No implementation support
drug
lead_sponsor
University Hospital, Akershus
company
collaborator
University Hospital of North Norway
company
Helse Fonna Hospital Trust
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Torleif Ruud, MD, PhD
person